Total Payments
$7,128
2024 Payments
$1,702
Companies
30
Transactions
401
Medicare Patients
4,400
Medicare Billing
$392,092
Payment Breakdown by Category
Food & Beverage$6,831 (95.8%)
Education$297.49 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,831 | 398 | 95.8% |
| Education | $297.49 | 3 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $963.95 | 67 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $749.10 | 31 | $0 (2024) |
| Biogen, Inc. | $521.94 | 30 | $0 (2024) |
| Amgen Inc. | $504.72 | 17 | $0 (2024) |
| Genentech USA, Inc. | $500.92 | 27 | $0 (2024) |
| EMD Serono, Inc. | $462.59 | 27 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $423.91 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $403.88 | 27 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $375.45 | 28 | $0 (2024) |
| PFIZER INC. | $299.05 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,702 | 88 | Alexion Pharmaceuticals, Inc. ($242.48) |
| 2023 | $1,400 | 90 | ABBVIE INC. ($329.60) |
| 2022 | $1,074 | 68 | ABBVIE INC. ($244.54) |
| 2021 | $967.67 | 64 | Novartis Pharmaceuticals Corporation ($210.16) |
| 2020 | $681.98 | 41 | Allergan, Inc. ($209.29) |
| 2019 | $514.84 | 21 | Teva Pharmaceuticals USA, Inc. ($160.63) |
| 2018 | $475.83 | 16 | Teva Pharmaceuticals USA, Inc. ($260.61) |
| 2017 | $310.78 | 13 | Genentech USA, Inc. ($164.83) |
All Payment Transactions
401 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: PAIN | ||||||
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| 12/04/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.28 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.27 | General |
| Category: PAIN | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: PAIN | ||||||
| 10/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.96 | General |
| 10/30/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $100.00 | General |
| 10/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.02 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: PAIN | ||||||
| 10/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/02/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Neurology | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,040 | 1,205 | $269,498 | $96,456 |
| 2022 | 15 | 1,100 | 1,293 | $274,322 | $103,180 |
| 2021 | 13 | 1,124 | 1,292 | $247,382 | $97,930 |
| 2020 | 16 | 1,136 | 1,353 | $250,605 | $94,526 |
Total Patients
4,400
Total Services
5,143
Medicare Billing
$392,092
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 350 | $76,650 | $30,559 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $49,392 | $17,079 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 76 | $22,420 | $9,620 | 42.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 73 | $29,369 | $9,242 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 91 | $13,650 | $5,459 | 40.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 37 | 37 | $11,359 | $3,427 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 57 | $8,550 | $3,273 | 38.3% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 54 | 55 | $11,990 | $3,022 | 25.2% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 34 | 34 | $8,704 | $2,680 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,736 | $2,648 | 39.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 48 | 52 | $7,176 | $2,200 | 30.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 59 | 65 | $9,100 | $2,197 | 24.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,934 | $1,413 | 35.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 17 | $3,621 | $1,411 | 39.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 73 | 94 | $4,606 | $1,223 | 26.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 27 | $2,241 | $1,002 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 272 | 371 | $78,281 | $32,221 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 144 | 144 | $46,656 | $17,596 | 37.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 105 | 107 | $42,895 | $16,399 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 55 | 57 | $16,245 | $7,463 | 45.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 92 | $13,248 | $5,107 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 68 | $9,792 | $3,918 | 40.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 39 | 39 | $11,544 | $3,763 | 32.6% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 64 | 64 | $13,440 | $3,612 | 26.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 73 | 78 | $10,374 | $3,480 | 33.5% |
About James Goldring, M.D., PH.D
James Goldring, M.D., PH.D is a Neurology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992715775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Goldring, M.D., PH.D has received a total of $7,128 in payments from pharmaceutical and medical device companies, with $1,702 received in 2024. These payments were reported across 401 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,831).
As a Medicare-enrolled provider, Goldring has provided services to 4,400 Medicare beneficiaries, totaling 5,143 services with total Medicare billing of $392,092. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Saint Louis, MO
- Active Since 08/08/2006
- Last Updated 06/08/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992715775
Products in Payments
- UBRELVY (Drug) $633.66
- QULIPTA (Drug) $513.67
- Aimovig (Biological) $460.43
- NUPLAZID (Drug) $375.45
- TYSABRI (Biological) $263.32
- EMGALITY (Drug) $257.43
- AUBAGIO (Drug) $239.14
- NURTEC ODT (Drug) $221.79
- KESIMPTA (Drug) $207.23
- VUMERITY (Drug) $197.01
- Ocrevus (Biological) $190.50
- OCREVUS (Biological) $164.97
- ULTOMIRIS (Biological) $163.29
- AUSTEDO (Drug) $154.68
- VYEPTI (Biological) $149.26
- Mavenclad (Drug) $144.84
- Ponvory (Drug) $143.37
- UPLIZNA (Drug) $124.05
- Austedo XR (Drug) $108.54
- AJOVY (Biological) $107.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Saint Louis
Barry Singer
Neurology — Payments: $2.7M
Neurology $2.7M
Dr. Mark Tullman, M.d, M.D
Neurology — Payments: $2.1M
Neurology $2.1M
Dr. Robert Naismith, Md, MD
Neurology — Payments: $774,163
Neurology $774,163
Dr. Barbara Green, Md, MD
Neurology — Payments: $597,464
Neurology $597,464
Dr. Arun Varadhachary, Md, MD
Neurology — Payments: $373,665
Neurology $373,665
Dr. Anne Cross, Md, MD
Neurology — Payments: $270,789
Neurology $270,789